Evidence map›Paper›PMID 42471576›Full record

ArticleBMC infectious diseases2026

Age-stratified epidemiological and clinical predictors of laboratory-confirmed measles among suspected cases in Diyarbakır, Türkiye (2012-2024): a test-negative case-control study.

Derya Çağlayan, Ahmet Yusuf Çakırci̇, Hasip Kahraman, Çınar Demir Aktar, Ruken Turhan, Ömer Faruk Şeker, Mehmet Hakan Pamukçu, Murat Can, Hanife Hilal Andan

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Derya ÇağlayanDiyarbakır Provincial Directorate of Health, Public Health Department, Communicable Diseases Unit, Diyarbakır İl Sağlık Müdürlüğü, Aziziye Mahallesi Elazığ Caddesi No:96/6, Yenişehir, Diyarbakır, 21120, Türkiye. drderya_caglayan@yahoo.com.ORCID http://orcid.org/0000-0002-9088-5097
Ahmet Yusuf Çakırci̇Diyarbakır Provincial Directorate of Health, Public Health Department, Communicable Diseases Unit, Diyarbakır İl Sağlık Müdürlüğü, Aziziye Mahallesi Elazığ Caddesi No:96/6, Yenişehir, Diyarbakır, 21120, Türkiye.
Hasip KahramanDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Türkiye.
Çınar Demir AktarDiyarbakır Provincial Directorate of Health, Public Health Department, Communicable Diseases Unit, Diyarbakır İl Sağlık Müdürlüğü, Aziziye Mahallesi Elazığ Caddesi No:96/6, Yenişehir, Diyarbakır, 21120, Türkiye.
Ruken TurhanDiyarbakır Provincial Directorate of Health, Public Health Department, Communicable Diseases Unit, Diyarbakır İl Sağlık Müdürlüğü, Aziziye Mahallesi Elazığ Caddesi No:96/6, Yenişehir, Diyarbakır, 21120, Türkiye.
Ömer Faruk ŞekerDiyarbakır Provincial Directorate of Health, Public Health Department, Communicable Diseases Unit, Diyarbakır İl Sağlık Müdürlüğü, Aziziye Mahallesi Elazığ Caddesi No:96/6, Yenişehir, Diyarbakır, 21120, Türkiye.
Mehmet Hakan PamukçuDiyarbakır Provincial Directorate of Health, Public Health Department, Communicable Diseases Unit, Diyarbakır İl Sağlık Müdürlüğü, Aziziye Mahallesi Elazığ Caddesi No:96/6, Yenişehir, Diyarbakır, 21120, Türkiye.
Murat CanDiyarbakır Provincial Directorate of Health, Public Health Department, Communicable Diseases Unit, Diyarbakır İl Sağlık Müdürlüğü, Aziziye Mahallesi Elazığ Caddesi No:96/6, Yenişehir, Diyarbakır, 21120, Türkiye.
Hanife Hilal AndanDiyarbakır Provincial Directorate of Health, Public Health Department, Communicable Diseases Unit, Diyarbakır İl Sağlık Müdürlüğü, Aziziye Mahallesi Elazığ Caddesi No:96/6, Yenişehir, Diyarbakır, 21120, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMeasles elimination remains elusive in many countries, and resurgences occur even in previously controlled settings. We assessed age-specific clinical and epidemiological factors associated with laboratory-confirmed measles among suspected cases.

methodsIn this test-negative case-control study, we analyzed surveillance data from Diyarbakır, Türkiye (2012-2024). Cases and controls were defined by measles-specific IgM results. Cases were stratified into two age groups, individuals aged ≤ 1 year and individuals aged > 1 year, with controls selected using systematic sampling at a case-control ratio of 1:3. Univariable and multivariable logistic regression analyses estimated odds ratios (ORs) for demographic factors, vaccination status, seasonality, epidemic year, clinical symptoms, and hospitalization.

resultsAmong 3,868 individuals (967 cases, 2,901 controls), 32% of cases were ≤ 1 year of age. In infants, predictors included hospitalization (OR: 7.95; 95% CI:4.21-15), upper respiratory tract symptoms (OR: 3.20; 95% CI:1.87-5.48), age 7-9 months (OR: 4.16; 95% CI:2.33-7.41) and 10-12 months (OR: 5.28; 95% CI:3.03-9.20), and spring-summer season (OR: 2.08; 95% CI:1.14-3.82). Among individuals aged > 1 year, significant predictors were receipt of a single dose (OR: 3.64; 95% CI:1.09-12.15); being unvaccinated (OR: 16.13; 95% CI:4.77-54.54) or having unknown vaccination status (OR: 17.26; 95% CI:5.14-57.88); epidemic year (OR: 4.06; 95% CI:2.74-6.02); spring-summer season (OR: 1.80; 95% CI:1.21-2.69); fever (OR: 1.89; 95% CI:1.20-2.95); and hospitalization (OR: 2.24; 95% CI:1.39-3.62).

conclusionAmong suspected cases, age-specific predictors of laboratory-confirmed measles may support clinical suspicion, surveillance alertness, and prioritization of laboratory testing when interpreted alongside the local epidemiological context, including seasonality, vaccination coverage, and individual vaccination status. These findings may help guide regionally tailored surveillance and control efforts.

Indexed as

MeaslesAdolescentAdultAge FactorsAntibodies, ViralCase-Control StudiesChildChild, PreschoolFemaleHospitalizationHumansImmunoglobulin MInfantMaleMeasles VaccineMiddle AgedAntibodies, ViralImmunoglobulin MMeasles VaccineInfantsMeaslesPredictorsPublic healthVaccination

Identifiers

PMID42471576
PMCPMC13670607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.